Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bhavana Pothuri

Showing results (1-10 of 131) with videos related to

Pageof 14
Sort By:
Current Treatment Options in Oncology|February 4, 2006
Decompressive percutaneous gastrostomy tube use in gynecologic malignanciesLarissa Meyer, Bhavana Pothuri
Current Treatment Options in Oncology|April 12, 2022
Appropriate Selection of PARP Inhibitors in Ovarian CancerMaria Smith, Bhavana Pothuri
Gynecologic Oncology Research and Practice|March 3, 2017
Homologous recombination deficiency (HRD) testing in ovarian cancer clinical practice: a review of the literatureMelissa K Frey, Bhavana Pothuri
Nature Clinical Practice. Oncology|November 3, 2006
Ovarian cancer: a focus on management of recurrent diseaseThomas J Herzog, Bhavana Pothuri
Cancer Journal (Sudbury, Mass.)|December 14, 2021
Poly(ADP-Ribose) Polymerase Inhibitor Inhibition in Ovarian Cancer: A Comprehensive ReviewKathleen N Moore, Bhavana Pothuri
The Oncologist|January 10, 2013
The role of palliative surgery in gynecologic cancer casesJoanie Mayer Hope, Bhavana Pothuri
Gynecologic Oncology|March 27, 2016
The genetic prediction of risk for gynecologic cancersLeslie M Randall, Bhavana Pothuri
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 8, 2023
Frequency of actionable germline pathogenic variants identified through tumor next-generation sequencing in a gynecologic cancer cohortHannah Karpel, Elizabeth Manderski, Bhavana Pothuri
Gynecologic Oncology Reports|December 18, 2018
Successful treatment of platinum refractory ovarian clear cell carcinoma with secondary cytoreductive surgery and implantable transponder placement to facilitate targeted volumetric arc radiation therapyJulia Fehniger, Peter B Schiff, Bhavana Pothuri
Gynecologic Oncology|June 24, 2025
Missed opportunities: Germline testing following tumor sequencingHannah C Karpel, Simone Sasse, Bhavana Pothuri
Pageof 14

Showing results (1-10 of 131) with videos related to

Sort By:
Pageof 14
Current Treatment Options in Oncology|February 4, 2006
Decompressive percutaneous gastrostomy tube use in gynecologic malignanciesLarissa Meyer, Bhavana Pothuri
Current Treatment Options in Oncology|April 12, 2022
Appropriate Selection of PARP Inhibitors in Ovarian CancerMaria Smith, Bhavana Pothuri
Gynecologic Oncology Research and Practice|March 3, 2017
Homologous recombination deficiency (HRD) testing in ovarian cancer clinical practice: a review of the literatureMelissa K Frey, Bhavana Pothuri
Nature Clinical Practice. Oncology|November 3, 2006
Ovarian cancer: a focus on management of recurrent diseaseThomas J Herzog, Bhavana Pothuri
Cancer Journal (Sudbury, Mass.)|December 14, 2021
Poly(ADP-Ribose) Polymerase Inhibitor Inhibition in Ovarian Cancer: A Comprehensive ReviewKathleen N Moore, Bhavana Pothuri
The Oncologist|January 10, 2013
The role of palliative surgery in gynecologic cancer casesJoanie Mayer Hope, Bhavana Pothuri
Gynecologic Oncology|March 27, 2016
The genetic prediction of risk for gynecologic cancersLeslie M Randall, Bhavana Pothuri
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 8, 2023
Frequency of actionable germline pathogenic variants identified through tumor next-generation sequencing in a gynecologic cancer cohortHannah Karpel, Elizabeth Manderski, Bhavana Pothuri
Gynecologic Oncology Reports|December 18, 2018
Successful treatment of platinum refractory ovarian clear cell carcinoma with secondary cytoreductive surgery and implantable transponder placement to facilitate targeted volumetric arc radiation therapyJulia Fehniger, Peter B Schiff, Bhavana Pothuri
Gynecologic Oncology|June 24, 2025
Missed opportunities: Germline testing following tumor sequencingHannah C Karpel, Simone Sasse, Bhavana Pothuri
Pageof 14